Model DetailsLeukocyte lymphoma
Model Name |
Leukocyte lymphoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
systemic lymphoma • lymphoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte | Male |
11.4% (8 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
4.3% (3 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
18.75% (12 of 64 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
4.3% (3 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
11.1% (8 of 72 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
8.0% (61 of 766 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20% (14 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
25.7% (18 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
29.7% (19 of 64 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
28.6% (20 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
12.9% (9 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
22.9% (16 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
21.4% (15 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20% (14 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
8.6% (6 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
14.3% (10 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20.8% (15 of 72 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20.4% (156 of 766 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
8.1% (72 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
22.0% (196 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |